Holen Sie sich die Stockscreener-App
44.00
0.43%
-0.1913
Schlusskurs vom Vortag:
$44.19
Offen:
$44.3
24-Stunden-Volumen:
5,295
Relative Volume:
0.55
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.29%
1M Leistung:
-2.66%
6M Leistung:
+7.14%
1J Leistung:
+50.89%
1-Tages-Spanne:
$43.95
$44.36
1-Wochen-Bereich:
$42.11
$44.88
52-Wochen-Spanne:
$27.20
$51.42
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
43.95 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
325.06 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
658.40 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
661.38 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
265.76 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
588.18 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
Stock List: Research Stocks from Around the World - GuruFocus
Global X Genomics & Biotechnology ETF (GNOM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Understanding Momentum Shifts in (GNOM) - news.stocktradersdaily.com
GNOMZ Stock Fund Price and Chart — AQUISUK:GNOMZ - TradingView
IBBQ, GNOM, BIB: Biotech ETFs Offer Exposure to Healthcare Startup Companies - TipRanks
Biotech Stocks and Longevity Investing: Trends To Track - Newsweek
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - AOL.com
Biotech stocks and longevity investing: Trends to track - My Hudson Valley
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF Index OverviewStock Price, Quote and News - marketscreener.com
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
GNOM Technical Analysis & Stock Price Forecast - Intellectia AI
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - The Globe and Mail
Global X Genomics & Biotechnology ETF: Performance & Quotes, GNOM.EU Stock Price on Nasdaq Exchange - MarketScreener
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
GNOM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Behavioral Patterns of GNOM and Institutional Flows - Stock Traders Daily
EDGAR Filing Documents for 0001135428-20-000018 - SEC.gov
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026 - TipRanks
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
The long game: ASX ETFs to target amidst an ageing population - MSN
(GNOM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
5 Small-cap Biotech ETFs to Watch - Nasdaq
Entravision Communications (NYSE:EVC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Lakeland Financial (NASDAQ:LKFN) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
German American Bancorp (NASDAQ:GABC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
AlTi Global (NASDAQ:ALTI) Shares Pass Above Two Hundred Day Moving Average – What’s Next? - Defense World
Demand Brands (OTCMKTS:DMAN) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Mercury General (NYSE:MCY) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Riverview Bancorp (NASDAQ:RVSB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
IBBQ, GNOM, BIB: Gain Exposure to Healthcare Startups with Biotech ETFs - TipRanks
Chimerix Shares Approach Peak on Partner’s Rosy Forecast - AD HOC NEWS
Best Biotech ETFs to Buy in 2026 - The Motley Fool
How (GNOM) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (GNOM) Volatility - Stock Traders Daily
Moderna (MRNA) Stock Surge Boosts ETFs with High Exposure - GuruFocus
Moderna’s rally ripples through biotech and health care ETFs - Seeking Alpha
The Next Big Theme: January 2026 - Global X ETFs
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
FengHe Fund Management Pte. Ltd. Invests $36.48 Million in Ciena Corporation $CIEN - Defense World
Invesco BulletShares 2025 Corporate Bond ETF $BSCP Shares Bought by Farnam Financial LLC - Defense World
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):